Generated by All in One SEO v4.9.9, this is an llms.txt file, used by LLMs to index the site.

# DPP PROJECT

Developing Paediatric Primaquine

## Sitemaps

- [XML Sitemap](https://dpp-project.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Bonjour tout le monde !](https://dpp-project.org/bonjour-tout-le-monde/) - Bienvenue sur WordPress. Ceci est votre premier article. Modifiez-le ou supprimez-le, puis commencez à écrire !

## Pages

- [Welcome](https://dpp-project.org/) - We must not leave kids behind in our efforts to eliminate malaria. AboutPrimaquine has two key roles in malaria elimination – blocking the transmission of Plasmodium falciparum and the radical cure of P. vivax and P. ovale. A single, low dose of primaquine is given with standard treatment for transmission blocking while radical cure primaquine
- [Accueil](https://dpp-project.org/fr/accueil/) - Pour éliminer le paludisme, il faut orienter nos efforts vers les enfants. À proposLa primaquine a deux rôles clés dans l’élimination du paludisme : le blocage de la transmission de Plasmodium falciparum et le traitement radical de Plasmodium vivax et P. ovale. Dans le premier cas elle est délivrée en une dose unique faible en même temps que le traitement standard,
- [Privacy policy](https://dpp-project.org/privacy-policy/) - We are committed to user privacy. Our policy on protection of individuals with regard to the processing of personal data is based on Regulation (EU) 2016/679 and repealing Directive 95/46/EC (GDPR). Data collection Who is responsible for the data collection on this website? The data collected on this website are processed by the website operator.
- [Legal notice](https://dpp-project.org/legal-notice/) - Owner and Publisher : ReMeD – 35 Rue Daviel, 75013 Paris Email: info@remed.org Responsible editor : Julie Nguyen Pouplin ReMeD Email: julie.nguyen@remed.org Creative concept and technical set-up : Romain Jouan /// Graphic Design Mérignac – France www.romainjouan.com Copyright : All contents of this website are copyright by ReMeD. Please contact ReMeD should you require permission
- [Projet DPP](https://dpp-project.org/fr/projet/) - Stratégie Vision globaleLes traitements standards sont distribués par les autorités sanitaires nationales de chaque pays où le paludisme est endémique via des programmes mondiaux de lutte antipaludique. L’approvisionnement de ces médicaments essentiels est soutenu par le Fond Mondial, l’USAID et d’autres bailleurs internationaux, qui achètent uniquement des médicaments dont la qualité répond aux normes internationales. Cette condition peut
- [DPP project](https://dpp-project.org/project/) - Strategy Global visionAntimalarial drugs that are used in malaria control programmes are usually procured externally. Procurement is supported by the Global Fund, USAID and other international agencies but the purchased drugs should be quality-assured. This can be achieved by developing essential medicines through the World Health Organization (WHO) prequalification programme, which is essentially the same
- [Partenaires](https://dpp-project.org/fr/partenaires/) - Financeur Le deuxième programme EDCTP (EDCTP2) s’étend de 2014 à 2024 et vise à soutenir la recherche collaborative qui accélère le développement de nouvelles interventions cliniques pour prévenir ou traiter les maladies infectieuses liées à la pauvreté en Afrique subsaharienne. En 2019, l’EDCTP2 a appelé à proposer des projets de développement de formulations de médicaments pédiatriques pour les
- [Partners](https://dpp-project.org/partners/) - Funder info@gras.bf www.tropmedres.ac Other partners DPP Governance StructureResearchers Dr. Endalamaw GadisaWP Leader - AHRI + Open biography- Close biography Dr. Endalamaw Gadisa Belachew, Lead Researcher and Acting Directorate Director, Malaria and NTD research directorate. Born in 1972, Arsi, Ethiopia, Dr. Gadisa holds a Bachelor of Science in Applied Biology and Master of Science in Applied
- [Operations](https://dpp-project.org/operations/) - Prequalification Roadmap DPP PrequalificationAll formulation development and manufacture of the pilot and clinical batches will be conducted according to current Good Manufacturing Practice (cGMP), while the analyses will be performed in a GLP certified laboratory, following WHO international quality standards. BE studyThis classic, randomised, two-way, cross-over bioequivalence study will follow WHO guidelines. It will be conducted in
- [Opérations](https://dpp-project.org/fr/operations-fr/) - Préqualification Feuille de route Préqualification DPPL’ensemble du développement de la formulation et de la fabrication des lots pilotes et cliniques sera mené conformément aux Bonnes Pratiques de Fabrication (BPF), tandis que les analyses seront effectuées dans un laboratoire certifié BPL suivant les normes internationales de qualité de l’OMS. Etude de bioéquivalenceCette étude de bioéquivalence croisée classique, randomisée, bidirectionnelle, suit
- [Mentions légales (eng)](https://dpp-project.org/fr/mentions-legales/) - Owner and Publisher : ReMeD – 35 Rue Daviel, 75013 Paris Email: info@remed.org Responsible editor : Julie Nguyen Pouplin ReMeD Email: julie.nguyen@remed.org Creative concept and technical set-up : Romain Jouan /// Graphic Design Mérignac – France www.romainjouan.com Copyright : All contents of this website are copyright by ReMeD. Please contact ReMeD should you require permission
- [Contact & Information](https://dpp-project.org/fr/contact-information-fr/) - Contact Pour toute demande d’informations sur le projet DPP, vous pouvez nous contacter via ce formulaire. Nous vous répondrons dans les plus brefs délais. Contact Us - Fr Nom * Prénom Last * Nom E-mail * Téléphone Sujet * Message * Captcha Envoyer If you are human, leave this field blank. Δ PartenairesAccueil
- [Contact & Information](https://dpp-project.org/contact-information/) - Contact For any information about the DPP Project, you can contact us using this form. We will respond as soon as possible. Contact Us Name * First Last * Last Email * Phone Subject * Message * Captcha Send If you are human, leave this field blank. Δ PartnersWelcome
- [Politique de confidentialité (eng)](https://dpp-project.org/fr/politique-confidentialite/) - We are committed to user privacy. Our policy on protection of individuals with regard to the processing of personal data is based on Regulation (EU) 2016/679 and repealing Directive 95/46/EC (GDPR). Data collection Who is responsible for the data collection on this website? The data collected on this website are processed by the website operator.
- [Partners-old](https://dpp-project.org/partners_old/) - EDCTP funder info@gras.bf www.tropmedres.ac BiosketchDr Anne-Marie Pensé-LhéritierDr Anne-Marie Pensé-Lhéritier (HDR) is a Professor at Ecole de Biologie Industrielle (EBI) in France. Over the past 20 years, she has developed and worked on a drug sensory panel and has become an international reference for the evaluation of topical products and oral forms. Her expertise has been
- [Page d’exemple](https://dpp-project.org/page-d-exemple/) - Ceci est une page d’exemple. C’est différent d’un article de blog parce qu’elle restera au même endroit et apparaîtra dans la navigation de votre site (dans la plupart des thèmes). La plupart des gens commencent par une page « À propos » qui les présente aux visiteurs du site. Cela pourrait ressembler à quelque chose comme cela :

## Biosketch

- [Dr Catherine Tuleu](https://dpp-project.org/biosketch/dr-catherine-tuleu/) - Catherine TULEU, Docteur en Pharmacie, PhD, is Professor of Paediatric Pharmaceutics at the UCL School of Pharmacy, UK. Her research (over 100 papers; h = 24; ORCID 0000-0001-8384-357X) is inherently translational and ranges from formulation, process and methodology development to clinical implementation, integrating the following themes: children centric excipient research; reformulation and repurposing for better
- [Dr Anne-Marie Pensé-Lhéritier](https://dpp-project.org/biosketch/dr-anne-marie-pense-lheritier/) - Dr Anne-Marie Pensé-Lhéritier (HDR) is a Professor at Ecole de Biologie Industrielle (EBI) in France. Over the past 20 years, she has developed and worked on a drug sensory panel and has become an international reference for the evaluation of topical products and oral forms. Her expertise has been recognised by several national drug agencies

## Categories

- [Non classé](https://dpp-project.org/fr/category/non-classe/)

## Tags

- [Français](https://dpp-project.org/fr/)
- [English](https://dpp-project.org/)

## Biosketch Categories

- [EBI](https://dpp-project.org/biosketch_cat/ebi/)
- [UCL](https://dpp-project.org/biosketch_cat/ucl/)